research An Ode to Telogen Effluvium
The poem ends by asking for case reports on serious health issues like Telogen Effluvium.
Search
forResearch
5 / 1000+ results 
research A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.
research Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations
Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.
research Donor Site Preservation and Long-Term Management in Follicular Unit Extraction (FUE): A Structured Clinical Framework for Surgical Planning and Complication Prevention
Proper planning and careful extraction are crucial for successful and sustainable hair transplants.
research Redefining hormone resistance in prostate cancer
The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.
Community Join
5 / 1000+ resultscommunity Aggressive hairloss after three years on fin
The user experienced aggressive hair loss after three years on finasteride, despite previous success with the treatment and PRP sessions. They are considering trying dutasteride but are unsure about purchasing it online due to trust issues.
community Thinking of getting more aggressive with my w
A 31-year-old man using finasteride for a year is considering adding oral minoxidil or switching to topical minoxidil to address diffuse thinning, while also using a scalp massager and ketoconazole shampoo. Concerns include cardiovascular side effects, pet safety with topical minoxidil, and cost of telehealth services.
community Aggressive Hair Loss from 18 – 22: Beginning my Holy Crusade Against MPB
A user's experience with aggressive hair loss from age 18-22, and possible treatments to combat this such as Dut, oral minoxidil, and finasteride.
community Kintor Phase 2 Results released KX-826 (pyrilutamide)
Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.
community Pyrilutamide Phase 3 on its way
Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.
Clinics
1 / 4 results
Experts
— no results